Tandem Diabetes Care, Inc. Available-for-sale Securities, Amortized Cost Basis
Tandem Diabetes Care, Inc. (TNDM) had Available-for-sale Securities, Amortized Cost Basis of $27.45 million as of 2016-03-31, per its 10-Q filed 2016-04-28.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesAmortizedCost · last filed 2017-03-08
- 2016-03-31: Available-for-sale Securities, Amortized Cost Basis $27.45M.
- 2015-12-31: Available-for-sale Securities, Amortized Cost Basis $27.78M.
- 2015-09-30: Available-for-sale Securities, Amortized Cost Basis $38.33M.
- 2015-06-30: Available-for-sale Securities, Amortized Cost Basis $51.62M.
| Period end | Available-for-sale Securities, Amortized Cost Basis |
|---|---|
| 2016-03-31 | $27.45M 10-Q · filed 2016-04-28 |
| 2015-12-31 | $27.78M 10-K · filed 2017-03-08 |
| 2015-09-30 | $38.33M 10-Q · filed 2015-10-29 |
| 2015-06-30 | $51.62M 10-Q · filed 2015-07-30 |
| 2015-03-31 | $53.66M 10-Q · filed 2015-04-30 |
| 2014-12-31 | $36.04M 10-K · filed 2016-02-24 |
| 2014-09-30 | $44.30M 10-Q · filed 2014-11-06 |
| 2014-06-30 | $30.09M 10-Q · filed 2014-07-31 |
| 2014-03-31 | $33.93M 10-Q · filed 2014-05-06 |
| 2013-12-31 | $5.09M 10-K · filed 2015-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |